INCYTE Executive and Leadership Team

November, 2026

Leadership Overview

INCYTE has 4 executives leading key functions including strategy, financial operations, information technology, and medical research.

Committed to advancing life-changing science, INCYTE delivers innovative biopharmaceutical solutions to patients battling complex cancers. This organization prioritizes rigorous clinical development and commercial excellence to transform therapeutic standards across the global healthcare landscape.

Leadership Roles at INCYTE

  • Chief Executive Officer - Bill Meury
  • Executive Vice President & Chief Financial Officer - Suky Upadhyay
  • Vice President & Chief Information Officer - Andrew Blyton
  • Chief Medical Officer - Steven Stein
  • Bill Meury - Chief Executive Officer

    Bill Meury, the Chief Executive Officer at INCYTE, directs the overarching corporate strategy and long-term vision for the biopharmaceutical enterprise. Overseeing the commercialization of critical therapeutics like JAKAFI and Iclusig, the Chief Executive Officer ensures alignment between research milestones and market delivery. This leadership role involves constant engagement with the Board to optimize resource allocation for oncology drug development. By fostering a culture of scientific rigor, Meury drives the expansion of the company portfolio within the United States and beyond. The Chief Executive Officer maintains focus on sustainable growth while addressing the urgent needs of patients with myelofibrosis and leukemia. Through disciplined execution of business objectives, Bill Meury secures the competitive position of the firm in the highly regulated pharmaceutical sector, ultimately delivering value to stakeholders and patients alike.
    Bill Meury

    Suky Upadhyay - Executive Vice President & Chief Financial Officer

    Suky Upadhyay, the Executive Vice President & Chief Financial Officer at INCYTE, manages the financial health and capital allocation strategies of the organization. Overseeing fiscal planning, the Executive Vice President & Chief Financial Officer ensures the availability of funding for complex drug discovery and clinical trial programs. This role involves rigorous analysis of market trends to support the commercial success of kinase inhibitors and other oncology assets. By maintaining robust financial controls, Upadhyay supports the operational scale required for North American market dominance. The Executive Vice President & Chief Financial Officer collaborates with executive leadership to balance investment in innovation with profitability targets. Suky Upadhyay provides the necessary financial oversight to navigate the volatile biopharmaceutical landscape, ensuring that the company maintains the liquidity required to sustain long-term research initiatives and patient-focused therapeutic development.
    Suky Upadhyay

    Andrew Blyton - Vice President & Chief Information Officer

    Andrew Blyton, the Vice President & Chief Information Officer at INCYTE, architects the digital infrastructure and data management systems essential for modern biopharmaceutical operations. Overseeing the integration of advanced analytics, the Vice President & Chief Information Officer ensures that research teams possess the computational power to accelerate drug discovery processes. This role involves securing proprietary data assets while enabling seamless collaboration across global research sites. By implementing scalable technology solutions, Blyton supports the efficient commercialization of therapeutics like JAKAFI. The Vice President & Chief Information Officer aligns technical capabilities with the broader corporate mission to improve patient outcomes through data-driven insights. Andrew Blyton maintains the integrity of information systems, providing the backbone for clinical trial management and regulatory compliance. Through continuous digital transformation, the Vice President & Chief Information Officer enhances operational agility and supports the overall strategic goals of the firm.

    Steven Stein - Chief Medical Officer

    Steven Stein, the Chief Medical Officer at INCYTE, leads the clinical development and medical strategy for the entire therapeutic pipeline. Overseeing the transition of compounds from laboratory discovery to clinical application, the Chief Medical Officer ensures that all drug candidates meet the highest standards of safety and efficacy. This role involves managing complex interactions with regulatory bodies to facilitate the approval of treatments for myelofibrosis and chronic myeloid leukemia. By directing clinical trial design, Stein ensures that research efforts directly address unmet patient needs. The Chief Medical Officer collaborates with the commercial team to communicate the clinical value of the company portfolio to healthcare providers. Steven Stein maintains a focus on scientific excellence, driving the advancement of kinase inhibitors through rigorous testing phases. Through this medical leadership, the Chief Medical Officer shapes the future of oncology care and strengthens the market impact of the organization.

    Explore Leadership Teams in Manufacturing

    Frequently Asked Questions Regarding INCYTE Top Executives and Leadership Team

    Who leads INCYTE?
    INCYTE is led by Bill Meury (Chief Executive Officer), along with executives such as Suky Upadhyay (Executive Vice President & Chief Financial Officer) and Andrew Blyton (Vice President & Chief Information Officer).
    Who is part of INCYTE’s executive team?
    The executive team of INCYTE includes leaders such as Bill Meury (Chief Executive Officer), Suky Upadhyay (Executive Vice President & Chief Financial Officer), Andrew Blyton (Vice President & Chief Information Officer) and other senior executives.
    How many executives does INCYTE have?
    INCYTE has 4 executives leading key business areas.
    What roles are included in INCYTE’s leadership team?
    The leadership team of INCYTE includes roles such as Chief Executive Officer, Executive Vice President & Chief Financial Officer, Vice President & Chief Information Officer, Chief Medical Officer.